Mitochondria-derived peptides in aging and healthspan

J Clin Invest. 2022 May 2;132(9):e158449. doi: 10.1172/JCI158449.

Abstract

The mechanisms that explain mitochondrial dysfunction in aging and healthspan continue to be studied, but one element has been unexplored: microproteins. Small open reading frames in circular mitochondria DNA can encode multiple microproteins, called mitochondria-derived peptides (MDPs). Currently, eight MDPs have been published: humanin, MOTS-c, and SHLPs 1-6. This Review describes recent advances in microprotein discovery with a focus on MDPs. It discusses what is currently known about MDPs in aging and how this new understanding could add to the way we understand age-related diseases including type 2 diabetes, cancer, and neurodegenerative diseases at the genomic, proteomic, and drug-development levels.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Mitochondria
  • Peptides
  • Proteomics*

Substances

  • Peptides